v3.25.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Current Assets:    
Cash and Cash Equivalents $ 3,792,322 $ 2,454,684
Short-Term Investments 22,999,760 0
Prepaid Expenses and Other Current Assets 2,042,487 233,382
Collaboration Receivables 601,197 0
Tax Receivables 270,246 2,049,965
Total Current Assets 29,706,012 4,738,031
Non-Current Assets:    
Property and Equipment, Net 5,232 8,065
Restricted Cash 4,057 4,267
Intangible Assets and In-Process R&D, Net 6,687,100 8,813,850
Operating Lease Assets with Right-of-Use 57,170 106,890
Other Assets 24,913 40,767
Total Assets 36,484,484 13,711,870
Current Liabilities:    
Accounts Payable 415,590 206,260
Accrued Expenses 4,588,657 1,380,666
Accrued Collaboration Credit 981,111 0
Operating Lease Liabilities 23,355 47,069
Total Current Liabilities 6,008,713 1,633,995
Non-Current Liabilities:    
Contingent Consideration 4,191,490 5,128,959
Deferred Tax Liability 490,690 779,440
Non-Current Operating Lease Liabilities 33,815 59,822
Total Non-Current Liabilities 4,715,995 5,968,221
Total Liabilities 10,724,708 7,602,216
Commitments and Contingencies (Note 12)
Stockholders’ Equity:    
Preferred Stock 4 4
Common Stock, $0.01 Par Value: 150,000,000 and 50,000,000 shares authorized at December 31, 2024 and 2023, respectively; 3,000,788 and 856,182 shares issued and outstanding at December 31, 2024 and 2023, respectively 267,679 77,078
Additional Paid-In Capital 169,156,374 153,192,228
Accumulated Deficit (143,382,122) (146,976,855)
Accumulated Other Comprehensive Loss (282,159) (182,801)
Total Stockholders’ Equity 25,759,776 6,109,654
Total Liabilities and Stockholders’ Equity $ 36,484,484 $ 13,711,870
Common stock, shares authorized (in shares) 150,000,000 50,000,000

Source

10-K PDF XBRL Zip